134 related articles for article (PubMed ID: 18791352)
1. Adrenal incidentaloma: effects on bone metabolism.
Francucci CM; Caudarella R; Rilli S; Fiscaletti P; Ceccoli L; Boscaro M
J Endocrinol Invest; 2008 Jul; 31(7 Suppl):48-52. PubMed ID: 18791352
[TBL] [Abstract][Full Text] [Related]
2. [Glucocorticoid-induced osteoporosis: recent findings].
Angeli A; Osella G; Reimondo G; Terzolo M
Ann Ital Med Int; 2000; 15(1):47-55. PubMed ID: 10842891
[TBL] [Abstract][Full Text] [Related]
3. Eugonadal male patients with adrenal incidentalomas and subclinical hypercortisolism have increased rate of vertebral fractures.
Chiodini I; Viti R; Coletti F; Guglielmi G; Battista C; Ermetici F; Morelli V; Salcuni A; Carnevale V; Urbano F; Muscarella S; Ambrosi B; Arosio M; Beck-Peccoz P; Scillitani A
Clin Endocrinol (Oxf); 2009 Feb; 70(2):208-13. PubMed ID: 18547342
[TBL] [Abstract][Full Text] [Related]
4. Bone metabolism and mass in women with Cushing's syndrome and adrenal incidentaloma.
Francucci CM; Pantanetti P; Garrapa GG; Massi F; Arnaldi G; Mantero F
Clin Endocrinol (Oxf); 2002 Nov; 57(5):587-93. PubMed ID: 12390331
[TBL] [Abstract][Full Text] [Related]
5. Glucocorticoid-related bone changes from endogenous or exogenous glucocorticoids.
Warriner AH; Saag KG
Curr Opin Endocrinol Diabetes Obes; 2013 Dec; 20(6):510-6. PubMed ID: 24468753
[TBL] [Abstract][Full Text] [Related]
6. The glucocorticoid-induced leucine zipper gene (GILZ) expression decreases after successful treatment of patients with endogenous Cushing's syndrome and may play a role in glucocorticoid-induced osteoporosis.
Lekva T; Bollerslev J; Kristo C; Olstad OK; Ueland T; Jemtland R
J Clin Endocrinol Metab; 2010 Jan; 95(1):246-55. PubMed ID: 19875485
[TBL] [Abstract][Full Text] [Related]
7. Surgical versus conservative management for subclinical Cushing syndrome in adrenal incidentalomas: a prospective randomized study.
Toniato A; Merante-Boschin I; Opocher G; Pelizzo MR; Schiavi F; Ballotta E
Ann Surg; 2009 Mar; 249(3):388-91. PubMed ID: 19247023
[TBL] [Abstract][Full Text] [Related]
8. Bone changes associated with glucocorticoid excess.
Birkenhäger JC; van der Heul RO; Smeenk D; van der Sluys Veer J; van Seters AP
Proc R Soc Med; 1967 Nov; 60(11 Part 1):1134-6. PubMed ID: 6060708
[No Abstract] [Full Text] [Related]
9. Adrenal incidentalomas and subclinical Cushing's syndrome: diagnosis and treatment.
Mazzuco TL; Bourdeau I; Lacroix A
Curr Opin Endocrinol Diabetes Obes; 2009 Jun; 16(3):203-10. PubMed ID: 19390321
[TBL] [Abstract][Full Text] [Related]
10. Subclinical Cushing's syndrome in adrenal incidentalomas.
Terzolo M; Bovio S; Reimondo G; Pia A; Osella G; Borretta G; Angeli A
Endocrinol Metab Clin North Am; 2005 Jun; 34(2):423-39, x. PubMed ID: 15850851
[TBL] [Abstract][Full Text] [Related]
11. [Role of cortisol hypersecretion in the pathogenesis of osteoporosis].
Chiodini I; Scillitani A
Recenti Prog Med; 2008 Jun; 99(6):309-13. PubMed ID: 18710063
[TBL] [Abstract][Full Text] [Related]
12. [Secondary osteoporosis UPDATE. How to diagnose secondary osteoporosis and disorders presenting low bone mineral density].
Takeuchi Y
Clin Calcium; 2010 May; 20(5):665-71. PubMed ID: 20445277
[TBL] [Abstract][Full Text] [Related]
13. Osteoporosis associated with excess glucocorticoids.
Shaker JL; Lukert BP
Endocrinol Metab Clin North Am; 2005 Jun; 34(2):341-56, viii-ix. PubMed ID: 15850846
[TBL] [Abstract][Full Text] [Related]
14. Nonfunctioning adrenocorticalcarcinoma.
Bakthavathsalam G; Shanmugasundaram VP; Prabakaran J; Venkatesh SP; Sowndaravalli DV; Jain CB
Int Surg; 2008; 93(2):81-7. PubMed ID: 18998286
[TBL] [Abstract][Full Text] [Related]
15. [Functional mechanism of glucocorticoid in bone turnover and bone structure].
Ikeda S; Akahoshi S; Sakai A; Nakamura T
Clin Calcium; 2006 Nov; 16(11):1805-11. PubMed ID: 17079846
[TBL] [Abstract][Full Text] [Related]
16. [Adrenal incidentalomas: etiologic diagnostics and basic therapeutic management. A mini-review].
Alberti C
G Chir; 2009 May; 30(5):243-50. PubMed ID: 19505420
[TBL] [Abstract][Full Text] [Related]
17. Secondary diabetes associated with principal endocrinopathies: the impact of new treatment modalities.
Resmini E; Minuto F; Colao A; Ferone D
Acta Diabetol; 2009 Jun; 46(2):85-95. PubMed ID: 19322513
[TBL] [Abstract][Full Text] [Related]
18. Adrenal incidentalomas and cardiometabolic morbidity: an emerging association with serious clinical implications.
Peppa M; Koliaki C; Raptis SA
J Intern Med; 2010 Dec; 268(6):555-66. PubMed ID: 20964741
[TBL] [Abstract][Full Text] [Related]
19. [Effect of glucose and bone metabolism in endocrinal disorder].
Takeshita M; Mizuno Y
Clin Calcium; 2009 Sep; 19(9):1282-90. PubMed ID: 19721199
[TBL] [Abstract][Full Text] [Related]
20. Bone involvement in eugonadal male patients with adrenal incidentaloma and subclinical hypercortisolism.
Chiodini I; Tauchmanovà L; Torlontano M; Battista C; Guglielmi G; Cammisa M; Colao A; Carnevale V; Rossi R; Di Lembo S; Trischitta V; Scillitani A
J Clin Endocrinol Metab; 2002 Dec; 87(12):5491-4. PubMed ID: 12466342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
